Literature DB >> 14758566

Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis.

C Otte1, J-M Otte, D Strodthoff, S R Bornstein, U R Fölsch, H Mönig, S Kloehn.   

Abstract

Leptin is involved in the regulation of food intake and is mainly secreted by adipocytes. Major secretagogues are cytokines such as TNF-alpha or IL-1. Leptin in turn upregulates inflammatory immune responses. Elevated leptin serum levels have been detected in patients with liver cirrhosis, a disease frequently associated with elevated levels of circulating cytokines as well as hypermetabolism and altered body weight. Recently, leptin has been detected in activated hepatic stellate cells in vitro and an involvement of leptin in liver fibrogenisis has been suggested. The current study was designed to further clarify the role of leptin in liver disease by characterizing leptin and leptin receptor expression in the development and onset of experimental liver fibrosis. Liver fibrosis and cirrhosis was induced in rats by use of phenobarbitone and increasing doses of CCl (4). Leptin and leptin receptor mRNA expression was determined by semiquantitative RT-PCR, protein expression by Western blot analysis and localization of leptin and its receptor by immunohistochemistry. Normal liver tissue does not express leptin, but leptin receptor mRNA. Increasing levels of leptin mRNA were detected in fibrotic and cirrhotic livers correlated to the degree of fibrosis. Leptin receptor mRNA expression was not significantly altered in damaged livers. Increasing levels of leptin were detected in fibrotic and cirrhotic livers, whereas protein expression of the receptor remained unchanged. Throughout different stages of liver fibrosis, leptin immunoreactivity was localized in activated hepatic stellate cells only, whereas immunoreactivity for the receptor was mainly seen on hepatocytes. In conclusion, leptin is expressed at increasing levels in activated hepatic stellate cells in vivo, which may therefore be a source of increased leptin tissue and serum levels contributing to the pathophysiology and morphological changes of chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14758566     DOI: 10.1055/s-2004-815720

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  22 in total

1.  Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease.

Authors:  Valentina Medici; Mohamed R Ali; Suk Seo; Christopher A Aoki; Lorenzo Rossaro; Kyoungmi Kim; Will D Fuller; Tamas J Vidovszky; William Smith; Joy X Jiang; Kalyani Maganti; Peter J Havel; Amit Kamboj; Rajendra Ramsamooj; Natalie J Török
Journal:  Obesity (Silver Spring)       Date:  2010-05-06       Impact factor: 5.002

2.  Insulin resistance and hepatitis C.

Authors:  Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

3.  Repeated whiskey binges promote liver injury in rats fed a choline-deficient diet.

Authors:  Natalia Nieto; Marcos Rojkind
Journal:  J Hepatol       Date:  2006-11-02       Impact factor: 25.083

Review 4.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

5.  FunRes: resolving tissue-specific functional cell states based on a cell-cell communication network model.

Authors:  Sascha Jung; Kartikeya Singh; Antonio Del Sol
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

Review 6.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

7.  Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.

Authors:  Tarek E Korah; Sawsan El-Sayed; Maathir K Elshafie; Ghada E Hammoda; Manal A Safan
Journal:  World J Hepatol       Date:  2013-02-27

Review 8.  The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).

Authors:  Marina Nati; David Haddad; Andreas L Birkenfeld; Christian A Koch; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

Review 9.  Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.

Authors:  Inaam A Nakchbandi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

10.  Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C.

Authors:  Robert P Myers; Djamila Messous; Thierry Poynard; Francoise Imbert-Bismut
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.